News & Analysis as of

US Trade Policies › Trump Administration › Comment Period

Holland & Knight LLP

Trump Administration Initiates Section 232 Investigation into Pharmaceuticals

Holland & Knight LLP on

The U.S. Department of Commerce announced that it has initiated a Trade Expansion Act of 1962 Section 232 investigation to determine whether imports of pharmaceutical products and ingredients pose a national security risk to...more

Holland & Knight LLP

USTR Seeks Public Comment on Unfair and Non-Reciprocal Foreign Trade Practices

Holland & Knight LLP on

The U.S. Trade Representative (USTR) is seeking comments on the Trump Administration's "Fair and Reciprocal Plan" to assist it in identifying any unfair trade or non-reciprocal foreign trade practices. The deadline for...more

Lowenstein Sandler LLP

Section 301 Tariff Update: USTR Now Accepting List 3 Exclusion Extension Comments

Lowenstein Sandler LLP on

The Office of the United States Trade Representative (USTR) is now accepting comments regarding the possible extension of List 3 product exclusions that are set to expire on August 7. Companies are invited to submit comments...more

Hogan Lovells

USTR invites comments on potential Section 301 exclusions in response to the coronavirus

Hogan Lovells on

The Office of the U.S. Trade Representative (USTR) has announced it is accepting comments on potential Section 301 tariff exclusions for Chinese imports necessary to respond to the coronavirus. USTR is likely to expeditiously...more

King & Spalding

USTR Announces Fourth Group of Chinese Products to Be Subject to Additional Tariffs as A Result of Section 301 Investigation;...

King & Spalding on

USTR on May 13, 2019 announced that it proposed to impose additional tariffs on products of China with an annual trade of approximately $300 billion pursuant to a Section 301 investigation commenced in August 2017 regarding...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide